ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $268,180,000 | -21.4% | 6,634,838 | +11.9% | 8.50% | -8.1% |
| Q2 2015 | $341,238,000 | -6.5% | 5,929,426 | +3.5% | 9.25% | -14.9% |
| Q1 2015 | $364,793,000 | -1.1% | 5,729,426 | -4.1% | 10.87% | -9.1% |
| Q4 2014 | $368,991,000 | +43.2% | 5,976,526 | -9.9% | 11.95% | +14.1% |
| Q3 2014 | $257,696,000 | +11.5% | 6,636,526 | -1.0% | 10.48% | -4.6% |
| Q2 2014 | $231,040,000 | -15.1% | 6,706,526 | +6.4% | 10.98% | -21.8% |
| Q1 2014 | $272,289,000 | +6.5% | 6,301,526 | -1.8% | 14.04% | +2.8% |
| Q4 2013 | $255,675,000 | -5.4% | 6,417,548 | -10.9% | 13.66% | -7.1% |
| Q3 2013 | $270,385,000 | +29.5% | 7,202,585 | -7.3% | 14.71% | -2.2% |
| Q2 2013 | $208,758,000 | – | 7,769,172 | – | 15.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |